Cell And Gene Therapies Global Clinical Trial Landscape (2018-2022)

Cell and gene therapies are poised to revolutionize medicine, offering remarkable potential to combat life-threatening diseases by harnessing our body's own defenses. These innovative therapies bring hope to patients with incurable conditions, spanning cancer, central nervous system disorders, and musculoskeletal ailments. Recent years have witnessed a surge in interest, drawing investors, healthcare professionals, and researchers globally, highlighting the transformative impact and promise of these treatments.

From 2018 to 2022, over 2,000 clinical trials worldwide explored new treatment avenues for various life-threatening and rare diseases. The Asia-Pacific (APAC) region, particularly China and the United States, played a pivotal role in driving these trials. Oncology, with a focus on haematological tumors, emerged as the primary therapeutic area, featuring cell, gene, and gene-modified cell therapies, including CAR-T cells, targeting cancer.

More than 40% of these trials involved gene-modified cell treatments, offering personalized disease targeting. The majority of trials (almost 70%) were conducted in a single location, with the APAC region leading in efficiency and speed of research. Funding for cell and gene therapy R&D also surged globally, with the United States, China, and Europe receiving significant investments, particularly in cancer therapies.

Automation has become a critical strategy to address the complexities and costs of cell and gene manufacturing, accelerating production, reducing expenses, and expediting market entry using intuitive software and AI-based solutions. This automation enhances accessibility to these therapies for future patients.

In summary, the rapid growth of cell and gene therapy research and development from 2018 to 2022, led by the APAC region in clinical trials and the United States and China in funding, holds great promise for the future of healthcare. Access the whitepaper below to dive into how the advancements in technology are heralding a brighter future for patients worldwide, offering new hope and improved healthcare outcomes.